Actively Recruiting
Open-Label Study of EscharEx EX-02 Gel for Treating Basal Cell Carcinoma on the Trunk and Upper Arms
Led by MediWound Ltd · Updated on 2021-12-15
32
Participants Needed
3
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of EscharEx EX-02 in treating basal cell carcinoma, a type of skin cancer. This open-label, multicenter study focuses on patients with a single primary superficial or nodular basal cell carcinoma lesion measuring 5 to 10 mm on the trunk or upper extremities, excluding hands. The purpose is to assess how well the topical treatment works and monitor any treatment-related side effects. All participants will receive the investigational EscharEx 5% gel applied topically in a thick layer to the lesion and surrounding margin for 8 to 12 hours per application. The treatment involves 7 applications in total, with two groups receiving different schedules the first group applies the gel every other day over two weeks, and the second group applies it daily for one week, adjusted based on safety and tolerability. After treatment, patients will undergo surgical excision of the lesion and be followed until the lesion clearance and wound closure are confirmed. Participants will be involved in multiple stages including a screening period of up to two weeks, a treatment period of 1 to 3 weeks with 10 to 14 clinic visits for application and assessment, an 8-week post-treatment period with bi-weekly follow-ups to monitor wound healing, and a follow-up phase after surgical excision to confirm complete clearance. Assessments include photography of the lesion, adverse event monitoring, vital signs, pain evaluations, and local lab tests. The total duration of participation is approximately 14 to 17 weeks.
CONDITIONS
Brief Title
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Research Team
L
Limor Dinur Klein, PhD
K
Keren David, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here